Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Body Fat Reduction Market, by Service Provider
1.4.2 North America Body Fat Reduction Market, by Gender
1.4.3 North America Body Fat Reduction Market, by Procedure
1.4.4 North America Body Fat Reduction Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Body Fat Reduction Market by Service Provider
3.1 North America Hospitals & Clinics Market by Country
3.2 North America Medical spas Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Body Fat Reduction Market by Gender
4.1 North America Female Body Fat Reduction Market by Country
4.2 North America Male Body Fat Reduction Market by Country
Chapter 5. North America Body Fat Reduction Market by Procedure
5.1 North America Surgical Market by Country
5.2 North America Non-Surgical Market by Country
Chapter 6. North America Body Fat Reduction Market by Country
6.1 US Body Fat Reduction Market
6.1.1 US Body Fat Reduction Market by Service Provider
6.1.2 US Body Fat Reduction Market by Gender
6.1.3 US Body Fat Reduction Market by Procedure
6.2 Canada Body Fat Reduction Market
6.2.1 Canada Body Fat Reduction Market by Service Provider
6.2.2 Canada Body Fat Reduction Market by Gender
6.2.3 Canada Body Fat Reduction Market by Procedure
6.3 Mexico Body Fat Reduction Market
6.3.1 Mexico Body Fat Reduction Market by Service Provider
6.3.2 Mexico Body Fat Reduction Market by Gender
6.3.3 Mexico Body Fat Reduction Market by Procedure
6.4 Rest of North America Body Fat Reduction Market
6.4.1 Rest of North America Body Fat Reduction Market by Service Provider
6.4.2 Rest of North America Body Fat Reduction Market by Gender
6.4.3 Rest of North America Body Fat Reduction Market by Procedure
Chapter 7. Company Profiles
7.1 Allergan PLC (AbbVie)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisitions and Mergers:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Approvals and Trials:
7.2 Bausch Health Companies, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Cutera, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Geographical Expansions:
7.3.5.3 Approvals and Trials:
7.4 Alma Lasers Ltd. (Sisram Medical Ltd.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Vlcc Health Care Limited
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.6 Apollo Hospitals Enterprise Limited
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.7 Candela Medical Corporation
7.7.1 Company Overview
7.8 Sciton, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Product Launches and Product Expansions:
7.9 Lumenis Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Geographical Expansions:
7.10. Cynosure, LLC
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Geographical Expansions:
Unique Offerings 